LAKE FOREST, Calif., April 06, 2017 -- InMode Aesthetic Solutions®, a leader in aesthetic medicine and technology, is proud to announce the launch of the brand’s newest procedure, BodyTite. This non-excisional device utilizes radio-frequency assisted lipolysis (RFAL) to address the shortcomings often associated with traditional liposuction or surgical body and face lifts, including sagging or wrinkly skin and scarring, by inserting a wand under the skin to coagulate inside while tightening the skin on top.
With over one hundred surgical practices in North America already utilizing the new technology, doctors can ensure their patients receive surgical-like procedures with limited downtime and without scars. The FDA approved technology, for use on the stomach, arms, chest, knees and inner/outer thighs, is minimally invasive and leaves virtually no scarring. Results can be seen immediately after one treatment and are more evident over three to six months post-treatment.
Previously, patients looking for fat reduction treatments had limited options including multiple non-invasive treatments with limited skin contraction results, a surgical tummy tuck with downtime or a brachioplasty, leaving large excision scars. These options left patients who wanted less invasive procedures without a solution, or unhappy with the results of their treatment. With BodyTite, doctors are able to ensure patients receive minimally invasive, effective procedures and offer powerful aesthetic results.
“Traditional surgery can leave permanent scars, and does not really fix the problem -- soft tissue with no internal support framework,” Diane Duncan, M.D., Fort Collins CO, a practitioner of BodyTite explains. “This new device is providing that internal structure reorganization, and in addition, has been proven to create up to 36.4% skin surface area contraction at one year” (Duncan, Aesthetic Surgery Journal, 2016).
“BodyTite is one of many technological innovations to come from InMode this year,” says Erik Dowell, CEO of InMode North America. “With our enhanced management team, we are looking forward to showcasing the advances we are making to the cosmetic industry to doctors and patients alike.”
About InMode: InMode’s technological advancements have become the new standard for aesthetic medicine, specifically in the radio-frequency aesthetic market. For more than three decades our R&D team was critical in developing state-of-the-art light, laser and radio-frequency devices, thereby launching and shaping the industry. Our technology continues that legacy in providing superior satisfaction for both the patient and the practice. Learn more about InMode technologies by visiting www.inmodemd.com.
Press Contact: Gianna Visconti | The Woods & Co [email protected] | 212.838.1878


China Considers New Rules to Limit Purchases of Foreign AI Chips Amid Growing Demand
Rio Tinto and BHP Agree to Explore Major Iron Ore Collaboration in Pilbara
China Halts Shipments of Nvidia H200 AI Chips, Forcing Suppliers to Pause Production
Anthropic Appoints Former Microsoft Executive Irina Ghose to Lead India Expansion
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
Jamie Dimon Signals Possible Five More Years as JPMorgan CEO Amid Ongoing Succession Speculation
Boeing Reaches Tentative Labor Deal With SPEEA Workers After Spirit AeroSystems Acquisition
Publishers Seek to Join Lawsuit Against Google Over Alleged AI Copyright Infringement
Saks Global Files for Bankruptcy Protection Amid Mounting Luxury Retail Pressures
Walmart International CEO Kathryn McLay to Step Down After Two and a Half Years
California Attorney General Orders xAI to Halt Illegal Grok Deepfake Imagery
China’s AI Models Narrow the Gap With the West, Says Google DeepMind CEO
TSMC Shares Hit Record High as AI Chip Demand Fuels Strong Q4 Earnings
TikTok Expands AI Age-Detection Technology Across Europe Amid Rising Regulatory Pressure
U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales
Chevron Set to Expand Venezuela Operations as U.S. Signals Shift on Oil Sanctions
Federal Judge Clears Way for Jury Trial in Elon Musk’s Fraud Lawsuit Against OpenAI and Microsoft 



